Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03450577 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Bifurcation Study

Study acronym: IBS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 11, 2019 (before its estimated December 31, 2021 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 31, 2018 to Dec 31, 2021
    • Study completion date: Dec 31, 2022 to Dec 31, 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The IBS registry is an observational, multi-center, real-world registry of stenting in coronary bifurcation lesions that will collect information on procedures and outcomes from various participating centers. The aim of this registry is to investigate long-term clinical results and predictors of adverse outcomes after PCI for coronary bifurcation lesions among various participating centers.
Trial Details
NCT Number NCT03450577
Lead Sponsor Meshalkin Research Institute of Pathology of Circulation
Conditions
(from sponsor)		 Coronary Bifurcation Lesion
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov